IRIS
PEROSA, Federico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.133
AS - Asia 4.848
EU - Europa 4.153
SA - Sud America 1.322
AF - Africa 188
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 9
Totale 20.669
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.981
SG - Singapore 2.100
CN - Cina 1.065
RU - Federazione Russa 1.053
BR - Brasile 1.044
IT - Italia 700
HK - Hong Kong 645
SE - Svezia 531
DE - Germania 398
UA - Ucraina 394
VN - Vietnam 308
FI - Finlandia 304
FR - Francia 292
GB - Regno Unito 225
IN - India 148
BD - Bangladesh 121
AR - Argentina 105
ID - Indonesia 70
IQ - Iraq 62
TR - Turchia 62
CA - Canada 60
EC - Ecuador 49
MX - Messico 46
PL - Polonia 39
ZA - Sudafrica 39
IE - Irlanda 35
JP - Giappone 35
CO - Colombia 33
NL - Olanda 32
UZ - Uzbekistan 32
PK - Pakistan 30
BE - Belgio 29
CI - Costa d'Avorio 29
MA - Marocco 28
SA - Arabia Saudita 27
CL - Cile 25
ES - Italia 25
AT - Austria 24
PH - Filippine 23
VE - Venezuela 22
JO - Giordania 19
TN - Tunisia 19
PY - Paraguay 17
AU - Australia 15
KE - Kenya 15
MY - Malesia 13
EG - Egitto 12
PE - Perù 12
AZ - Azerbaigian 11
CR - Costa Rica 11
DO - Repubblica Dominicana 11
IR - Iran 11
DZ - Algeria 10
RO - Romania 10
LT - Lituania 9
PS - Palestinian Territory 9
AL - Albania 8
HR - Croazia 8
EU - Europa 7
UY - Uruguay 7
BO - Bolivia 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
KG - Kirghizistan 5
NP - Nepal 5
PA - Panama 5
RS - Serbia 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AO - Angola 4
ET - Etiopia 4
IL - Israele 4
JM - Giamaica 4
LB - Libano 4
MD - Moldavia 4
MK - Macedonia 4
NG - Nigeria 4
SN - Senegal 4
SY - Repubblica araba siriana 4
AM - Armenia 3
BB - Barbados 3
CZ - Repubblica Ceca 3
KR - Corea 3
OM - Oman 3
PT - Portogallo 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CG - Congo 2
DK - Danimarca 2
GE - Georgia 2
GH - Ghana 2
GR - Grecia 2
HN - Honduras 2
KH - Cambogia 2
KZ - Kazakistan 2
QA - Qatar 2
TG - Togo 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BF - Burkina Faso 1
Totale 20.637
Salva come PNG Salva come JPEG
Città #
Singapore 1.135
Chandler 927
Jacksonville 914
Ashburn 911
Fairfield 858
Woodbridge 663
Hong Kong 640
San Jose 509
Houston 507
Ann Arbor 396
Nyköping 377
Seattle 359
Cambridge 354
Wilmington 324
Bari 314
Beijing 278
Lawrence 201
Roxbury 200
Nanjing 196
Lauterbourg 191
New York 164
Des Moines 133
Los Angeles 131
Boardman 129
Helsinki 110
Ho Chi Minh City 94
Dallas 90
Princeton 90
São Paulo 76
Hanoi 68
Inglewood 66
Santa Clara 66
Brooklyn 60
Buffalo 56
Nanchang 55
Shenyang 50
London 49
Hebei 47
Moscow 42
Chicago 40
Rio de Janeiro 39
San Diego 39
Munich 37
Pune 37
Falkenstein 35
Tokyo 34
Orem 33
Jiaxing 32
Jakarta 30
Abidjan 29
Dublin 28
Tashkent 28
Tianjin 28
Brussels 27
Frankfurt am Main 27
Belo Horizonte 26
Changsha 26
Council Bluffs 26
Paris 25
Montreal 24
Rome 24
Guangzhou 23
Warsaw 23
Chennai 22
Quito 22
Stockholm 22
Amsterdam 21
Atlanta 21
Baghdad 21
Curitiba 21
Denver 21
Nuremberg 21
Dhaka 20
Noicattaro 19
Boston 18
Johannesburg 18
Milan 18
Amman 17
Haiphong 17
Poplar 17
Porto Alegre 17
Toronto 17
Brasília 16
Dong Ket 16
Dearborn 15
Marseille 15
Medellín 15
Mexico City 15
San Francisco 15
Vienna 15
Washington 15
Campinas 14
Falls Church 14
Buenos Aires 13
Grafing 13
Guayaquil 13
Auburn Hills 12
Radomsko 12
Ankara 11
Columbus 11
Totale 13.170
Salva come PNG Salva come JPEG
Nome #
Response to "Is active acid sphingomyelinase required for the antiproliferative response to rituximab?" [e-letter]. http://bloodjournal.hematologylibrary.org/content/117/13/3695.citation/reply#bloodjournal_el_2268 755
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association 204
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading 186
Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis 180
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin 176
Autoantibodies Recognizing the Amino Terminal 1-17 Segment of CENP-A Display Unique Specificities in Systemic Sclerosis 170
Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections 170
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic 168
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 168
MHC Class i Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells 167
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases 162
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 159
Autoantibodies to intracellular antigens: generation and pathogenetic role 159
AB0695 Subspecificities of Anti-Centromeric-Associated Protein a (CENP-A) Antibodies (AB) Can Identified a Subset of Patients at Higher Risk of Developing Pulmonary Hypertension 152
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease 151
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis 147
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders. 145
CD20 mimicry by a mAb rituximab-specific linear peptide: A potential tool for active immunotherapy of autoimmune diseases 142
Antiphospholipids syndrome complicated by a systemic capillary leak-like syndrome treated with steroids and intravenous immunoglobulins a case report 142
Absence of streptococcal protein G (PG)-specific determinant in the Fab region of human IgG2 141
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype 139
Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature 136
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 136
Vasculitides: Proposal for an integrated nomenclature 134
CD20: A target antigen for immunotherapy of autoimmune diseases 131
Serological methods to detect anti-idiotypic antibodies 130
Effects of Adjuvants for Human Use in Systemic Lupus Erythematosus (Sle)-Prone (Nzb/Nzw) F1 Mice 129
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 129
Rheumatic disorders as paraneoplastic syndromes 128
Alternative splicing of HLA-C mRNA in HCV-infected hepatocytes reduces viral epitope-specific cytotoxicity T cell response and promotes NK activity 128
Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 127
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 126
Human CD4 internal antigen anti-idiotypic monoclonal antibody. Immunochemical and sequence analysis 126
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects 125
CD20 mimicry by mAb Rituximab-specific linear peptide. A potential tool for active immunotherapy of autoimmune diseases 124
Extra-articular manifestations of rheumatoid arthritis: an update 124
A sandwich assay to detect and characterize syngeneic anti-idiotypic antibodies to murine anti-HLA and tumor associated antigen monoclonal antibodies 124
Analisi molecolare di un anticorpo monoclonale (ACMO) anti-idiotipo 'immagine interna' dell'antigene CD4 123
Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor 122
Uso di un anticorpo monoclonale antiidiotipo di un anticorpo monoclonale anti-CD4 in pazienti con artrite reumatoide 121
Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease 120
B-T cell interaction in the pathogenesis of HCV-positive mixed cryoglobulinemia. 119
Subclinical and clinical atherosclerosis in rheumatoid arthritis: Results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 118
The Fab region of IgG2 human myeloma proteins does not bear the streptococcal protein G-specific determinant 117
Cinetica di produzione e clonotipia di anticorpi anti-anti-idiotipo (Ac3) in due pazienti affette da patologia autoimmune immunizzate con un anticorpo monoclonale anti-idiotipo (AcMo2) 114
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 114
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects 113
Identification of an antigenic and immunogenic motif expressed by two 7-Mer Rituximab-specific cyclic peptides 112
Immunogenicity of two idiotypes with a different immunoglobulin-chain distribution expressed on the same anti-CD4 Mab 112
Preparation, characterization and utilization of monoclonal antibodies to the gene products of the HLA-D region with special emphasis on those to polymorphic determinants 111
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? 111
Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment 111
Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma 108
The immunodominant epitope of centromere-associated protein A displays homology with the transcription factor forkhead box E3 (FOXE3) 108
Anticorpi monoclonali nell'immunoterapia delle malattie autoimmuni 107
Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes 107
Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors 107
Human anti-mouse antibodies interfere in the determination of sCD4 in intravenous immunoglobulin preparations 106
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 106
Beta2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide 105
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: Putative implication of a low anti-carbamylated protein antibodies prevalence 103
Syngeneic antiidiotypic monoclonal antibodies to the murine anti-HLA- DR,DP monoclonal antibody CR11-462 102
Syngeneic polyclonal and monoclonal antiidiotypic antibodies to murine anti-human high molecular weight-melanoma associated antigen and anti-HLA monoclonal antibodies 102
Analysis of beta-2 microglobulin (b2M), free HLA class I heavy chain (FHC) and the associated protein pattern in multiple myeloma (MM) patients from the Nordic Myeloma Group Study #5/94. Haematologica-the Hematology Journal 102
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count 101
Immunochemical and functional characterization of anti-idiotypic antibodies to a mouse anti-CD4 monoclonal antibody 101
Antigenic mimicry by linear peptides of the conformational epitope recognized by the anti-CD20 monoclonal antibody (mAb) Rituximab 100
L'AMILOIDOSI: QUADRI CLINICI, CARATTERISTICHE IMMUNOLOGICHE E BIOMOLECOLARI, PROSPETTIVE TERAPEUTICHE 100
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 100
Beta2-m-free heavy chain levels of HLA-class I antigen combined with serum IgM or platelet count provide two reliable staging systems in multiple myeloma 98
Evaluation of biotinylated cells as a source of antigens for characterization of their molecular profile 98
Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma 98
B2 microglobulin-free heavy chain (FHC) of HLA class I antigen in patients with Hodgkin’s and non Hodgkin’s lymphomas 98
Anti-idiotypic antibodies in therapy: current status and prospects 97
Analysis in a syngeneic and xenogeneic system of mouse antiidiotypic (Ab2) monoclonal antibodies (mAb) elicited with the syngeneic anti-CD4 mAb HP2/6 96
Murine antiidiotypic monoclonal antibodies that bear the internal image of HLA-DR allospecificities 95
Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic peptide mimotopes: Implication for peptide-based active immunotherapy 95
Analisi della risposta immune indotta da anticorpi monoclonali murini anti-idiotipo (Ab2) anti-CD4 in un sistema xenogenico 94
Anti-idiotypic monoclonal antibodies (mAb) to an anti-CD4 mAb induce CD4+ T cell depletion in rabbit 94
Soluble CD4 antigen reactivity in intravenous immunoglobulin preparations: is it specific? 94
Studi in vitro dell'attivita' antiallergica del Fenoterolo 93
Analisi della risposta immune indotta da anticorpi monoclonali murini anti-idiotipo (Ab2) anti-CD4 in un sistema xenogenico 93
Analisi molecolare di un anticorpo monoclonale (AcMo) anti-idiotipo “immagine interna” dell’antigene CD4 93
Prescribing motivations and patients’ characteristics related to the use of biologic drugs in adult-onset Still’s disease: analysis of a multicentre “real-life” cohort 93
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 92
Characterization of the specificity of the Human scFv W9 92
Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate 92
Vaccination against CD20 mimotope peptiide. Is it a feasible strategy for the treatment of autoimmune diseases? 91
Cloning and chromosomal localization of a cDNA encoding a mitochondrial porin from Drosophila melanogaster 91
Endothelial cells in tumor microenvironment: insights and perspectives 90
HLA allele prevalence in disease-modifying antirheumatic drugs-responsive enthesitis and/or arthritis not fulfilling ASAS criteria: Comparison with psoriatic and undifferentiated spondyloarthritis 90
Identificazione del peptide che mima l'epitopo localizzato sulla catena pesante HLA-I non associata alla beta 2-microglobulina, riconosciuto dall'anticorpo monoclonale HC-10 90
Raynaud’s phenomenon: from molecular pathogenesis to therapy 89
The proliferative transcriptional factor FOXE3 is the target of anti-CENP-A antibodies and identifies a subset of anti-CENP antibody positive systemic sclerosis patients 88
Vasculiti primarie sistemiche 87
Human CD4 "internal antigen" mimicry by anti-idiotypic monoclonal antibodies 87
Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification 87
Antiidiotype to anti-CD4 monoclonal antibody (mAb) as surrogate of human CD4 antigen (Ag) for active immunotherapy in autoimmune diseases 86
Anticorpi anti-DNA e network idiotipico nel LES: recenti progressi e prospettive terapeutiche 86
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 86
Totale 12.396
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.258
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021427 0 0 0 0 0 0 0 0 0 216 132 79
2021/20221.415 63 209 8 80 77 70 110 86 63 42 236 371
2022/20232.316 340 204 114 226 323 333 36 264 361 28 52 35
2023/2024856 63 140 43 91 65 221 25 66 6 16 39 81
2024/20253.228 99 48 332 77 68 260 249 281 105 155 479 1.075
2025/20266.782 971 270 398 824 756 414 999 225 1.310 615 0 0
Totale 21.062